Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 18;7(8):ofaa292. doi: 10.1093/ofid/ofaa292

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Changes in MERS-CoV concentrations in respiratory samples over time. A, Results of real-time reverse-transcriptase polymerase chain reactions; MERS-CoV RNA was detected in the sputum samples until 173 days after symptom onset. B, Results of viral culture; MERS-CoV was isolated from one sputum sample obtained at 34 days after symptom onset. C, Results of subgenomic mRNA assay; subgenomic mRNA was detected in the sputum collected at 34 days after symptom onset and 46 days after symptom onset. orf1, open reading frame 1; GDP, Gemcitabine/Cisplatin/Dexamethasone; ICE, Ifosfamide/carboplatin/etoposide.